Source: Virtual Congress 2021 – Tobacco and nicotine research during the pandemic



Rating:

Share or cite this content

Citations should be made in the following way:
G. Lyytinen (Stockholm, Sweden), A. Bryndal (Umeå, Sweden), E. Anesäter (Stockholm, Sweden), L. Antoniewicz (Vienna, Austria), A. Blomberg (Umeå, Sweden), J. Bosson (Umeå, Sweden), F. Mobarrez (Uppsala, Sweden), L. Hedman (Umeå, Sweden), S. Tehrani (Stockholm, Sweden), M. Lundbäck (Stockholm, Sweden). Late Breaking Abstract - Brief use of heated tobacco products causes increased arterial stiffness and thrombotic activity. 2585

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Contribution of STIM-activated TRPC-ORAI channels to the intermittent hypoxia-induced pulmonary hypertension Source: Virtual Congress 2020 – Cellular stress in respiratory diseases Year: 2020 Late Breaking Abstract - Physical activity recovery in patients with COVID-19 infection included in pulmonary rehabilitation Source: Virtual Congress 2021 – COVID-19: insights from respiratory physiotherapists Year: 2021 Late Breaking Abstract - Effects of pulmonary rehabilitation on major symptoms of long COVID (post-COVID-19 syndrome): preliminary results Source: Virtual Congress 2021 – A multidisciplinary approach to pulmonary rehabilitation and management of chronic respiratory diseases Year: 2021 Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19 Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Late Breaking Abstract - Relationship between obesity and aging of the pulmonary parenchyma Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020 Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - ‘Shielding’: Patient experience of measures to reduce risk of COVID-19 in those with pre-existing respiratory conditions Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Late Breaking Abstract - Pulmonary embolism in patients with COVID-19: Time to change thromboprophylaxis paradigm. Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension Year: 2020 Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy. Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Late Breaking Abstract - Inflammation and metabolic syndrome exacerbate pulmonary hypertension associated with left heart disease. Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - The impact of tabacco heating systems on haemodynamics Source: International Congress 2018 – Systematic reviews on the health effects of emerging tobacco products and electronic nicotine delivery systems (ENDS) Year: 2018 Late Breaking Abstract - Impact of an improvised system on preserving oxygen supplies in patients with COVID-19. Source: Virtual Congress 2020 – COVID-19 clinical studies Year: 2020 LSC - 2021 - Direct effects of cigarette smoke in pulmonary arterial cells: Implications in arterial remodeling and vascular tone maintenance Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Late Breaking Abstract - Rates and risk factors of respiratory symptoms during marathon running Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Late Breaking Abstract - Effects of preventive exercise in monocrotaline rat model with pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019 Late Breaking Abstract - Daily physical activity in patients with severe eosinophilic asthma and the effect of anti-IL5 therapy. Source: International Congress 2018 – New pharmacological strategies in airway diseases Year: 2018 Late Breaking Abstract - Chronic coronary artery disease and decline of lung function as predictors of mortality and exacerbation risk in stable COPD: Results from COSYCONET Source: Virtual Congress 2021 – Lung function evaluation and assessment of airway diseases Year: 2021 Late Breaking Abstract - Convergence of clinical and computational phenotypes for rare variant association study (RVAS) in pulmonary arterial hypertension Source: Virtual Congress 2021 – All about pulmonary arterial hypertension Year: 2021 Acute effects of active e-cigarette inhalation on arterial stiffness Source: International Congress 2017 – Electronic nicotine delivery systems (ENDS) Year: 2017 Late Breaking Abstract - Do face masks cause abnormal gas exchange during exercise testing in children? Source: Virtual Congress 2021 – Causes and consequences of paediatric respiratory diseases Year: 2021